463 related articles for article (PubMed ID: 18851683)
1. Epigenetics, DNA methylation, and chromatin modifying drugs.
Szyf M
Annu Rev Pharmacol Toxicol; 2009; 49():243-63. PubMed ID: 18851683
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
Mai A; Massa S; Rotili D; Cerbara I; Valente S; Pezzi R; Simeoni S; Ragno R
Med Res Rev; 2005 May; 25(3):261-309. PubMed ID: 15717297
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic targeting in pancreatic cancer.
van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches on epigenetics.
Papait R; Monti E; Bonapace IM
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
[TBL] [Abstract][Full Text] [Related]
5. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
8. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.
Franci G; Miceli M; Altucci L
Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
[TBL] [Abstract][Full Text] [Related]
10. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells.
Bar-Sela G; Jacobs KM; Gius D
Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248
[TBL] [Abstract][Full Text] [Related]
12. Switching on epigenetic therapy.
Karberg S
Cell; 2009 Dec; 139(6):1029-31. PubMed ID: 20005793
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
14. How to build a centromere: from centromeric and pericentromeric chromatin to kinetochore assembly.
Vos LJ; Famulski JK; Chan GK
Biochem Cell Biol; 2006 Aug; 84(4):619-39. PubMed ID: 16936833
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of autoimmune diabetes.
Jayaraman S
Epigenomics; 2011 Oct; 3(5):639-48. PubMed ID: 22126251
[TBL] [Abstract][Full Text] [Related]
17. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy.
Lunke S; El-Osta A
J Neurochem; 2009 Jun; 109(6):1557-69. PubMed ID: 19383090
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic therapy--a new development in pharmacology.
Peedicayil J
Indian J Med Res; 2006 Jan; 123(1):17-24. PubMed ID: 16567863
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
Vaissière T; Sawan C; Herceg Z
Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]